Correlation Between X4 Pharmaceuticals and Verrica Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Verrica Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Verrica Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Verrica Pharmaceuticals, you can compare the effects of market volatilities on X4 Pharmaceuticals and Verrica Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Verrica Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Verrica Pharmaceuticals.
Diversification Opportunities for X4 Pharmaceuticals and Verrica Pharmaceuticals
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between XFOR and Verrica is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Verrica Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verrica Pharmaceuticals and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Verrica Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verrica Pharmaceuticals has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Verrica Pharmaceuticals go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and Verrica Pharmaceuticals
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 1.05 times more return on investment than Verrica Pharmaceuticals. However, X4 Pharmaceuticals is 1.05 times more volatile than Verrica Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. Verrica Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest 66.00 in X4 Pharmaceuticals on August 31, 2024 and sell it today you would lose (27.00) from holding X4 Pharmaceuticals or give up 40.91% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
X4 Pharmaceuticals vs. Verrica Pharmaceuticals
Performance |
Timeline |
X4 Pharmaceuticals |
Verrica Pharmaceuticals |
X4 Pharmaceuticals and Verrica Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with X4 Pharmaceuticals and Verrica Pharmaceuticals
The main advantage of trading using opposite X4 Pharmaceuticals and Verrica Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Verrica Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verrica Pharmaceuticals will offset losses from the drop in Verrica Pharmaceuticals' long position.X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Verrica Pharmaceuticals vs. Cue Biopharma | Verrica Pharmaceuticals vs. Tff Pharmaceuticals | Verrica Pharmaceuticals vs. Eliem Therapeutics | Verrica Pharmaceuticals vs. Inhibrx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |